Ferring announces new analysis of Rekovelle® data relating to personalised medicine in fertility patients
-Ferring Pharmaceuticals announced today a new analysis of Rekovelle® (follitropin delta) data that showed cumulative live birth rates were similar…
Ferring appoints Lars Peter Brunse to Executive Board
-Ferring Pharmaceuticals announced today that Lars Peter Brunse has been appointed Executive Vice President and Chief Production Officer…
Paul Navarre joins Ferring Pharmaceuticals as Chief Executive Officer of Ferring Holding Inc.
-Ferring Pharmaceuticals announced today that Paul Navarre has been appointed Chief Executive Officer of Ferring Holding Inc…
Ferring appoints Aaron Graff to Executive Board
-Ferring Pharmaceuticals announced today that Aaron Graff has been appointed Executive Vice President and Chief Commercial Officer…
Ferring commits $10 million to March of Dimes to expand research needed to end preterm birth
-Ferring Pharmaceuticals and the March of Dimes Foundation announced today that Ferring has committed $10 million to support…
Archives Press release 2017
Archives Press release 2017